GE HealthCare has grown revenue 3.9% a year over three years and 4.1% a year over five, with earnings per share compounding at 3.5%. Revenue growth, 3-year annual rate: +3.9% (Medical Devices median +12%). Revenue growth, 5-year rate: +4.1%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +3.5%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 5, FY2021 to FY2025, as filed.

GEHCGE HealthCare

Healthcare

$65.74-11% 1Y

$65.74

$59.4952 weeks$88.08

Is it growing?

Watch

Growth is fading: earnings down −12% year on year and operating margin narrowing (−1.1 points).

2 to watch, 1 neutral

Revenue trend+6% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Earnings trend−12% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction−1.1 points operating

Trailing-twelve-month operating margin, 12.6% now against 13.7% a year earlier.

All from SEC EDGAR, as of Mar 31, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is GEHC growing?

GE HealthCare has grown revenue 3.9% a year over three years and 4.1% a year over five, with earnings per share compounding at 3.5%.

+3.9%

Revenue growth, 3-year annual rate · Medical Devices median +12% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +4.1%
Revenue growth, 5-year rate · +3.9% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +3.5%
Earnings per share, 3-year rate · revenue +3.9% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 5
Years of annual history on file · FY2021 to FY2025, as filed